athenahealth (athenahealth) Cash And Cash Equivalents : $303 Mil (As of Sep. 2018)

View and export this data going back to 2007. Start your Free Trial

What is athenahealth Cash And Cash Equivalents?

athenahealth's quarterly cash and cash equivalents increased from Mar. 2018 ($142.00 Mil) to Jun. 2018 ($222.10 Mil) and increased from Jun. 2018 ($222.10 Mil) to Sep. 2018 ($303.40 Mil).

athenahealth's annual cash and cash equivalents increased from Dec. 2015 ($141.90 Mil) to Dec. 2016 ($147.40 Mil) and increased from Dec. 2016 ($147.40 Mil) to Dec. 2017 ($165.10 Mil).

athenahealth Cash And Cash Equivalents Historical Data

The historical data trend for athenahealth's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

athenahealth Cash And Cash Equivalents Chart

athenahealth Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Cash And Cash Equivalents

Get a 7-Day Free Trial

65.00

73.79

141.90

147.40

165.10

athenahealth Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Cash And Cash Equivalents	Get a 7-Day Free Trial															122.70	165.10	142.00	222.10	303.40

athenahealth Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

athenahealth (NAS:ATHN) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

athenahealth Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of athenahealth's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

athenahealth (athenahealth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » athenahealth Inc (NAS:ATHN) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.athenahealth.com

Athenahealth provides healthcare IT (HCIT) services through cloud-based and mobile application products largely for smaller to midsize medical groups and health systems. Their services include revenue cycle and practice management, electronic health records, patient engagement, population health management, and care coordination. The business services segment generates 96% of revenue, which provides cloud-based solutions and support to healthcare providers. Athenahealth is headquartered in Waltham, Massachusetts.

Executives

Brian P Mckeon	director	IDEXX LABORATORIES, ONE IDEXX DRIVE, WESTBROOK ME 04092
John A Kane	director	C/O MERCHANTS BANCSHARES, INC., 275 KENNEDY DRIVE, SOUTH BURLINGTON VT 05403
Dev Ittycheria	director	C/O MONGO DB, INC., 1633 BROADWAY, 38TH FLOOR, NEW YORK NY 10019
Ed Park	director	311 ARSENAL STREET WATERTOWN MA 02472
Brandon H Hull	director	221 NASSAU STREET, PRINCETON NJ 08542
Thomas J Szkutak	director	P O BOX 81226, SEATTLE WA 98108-1226
Jeffrey R Immelt	director, other: Executive Chairman	GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210
Marc A Levine	officer: Chief Financial Officer	C/O ATHENAHEALTH, INC., 311 ARSENAL STREET, WATERTOWN MA 02472
Jacqueline B Kosecoff	director	5960 HEISLEY ROAD, MENTOR OH 44060
Amy Abernethy	director	311 ARSENAL STREET, WATERTOWN MA 02472
Kristi Ann Matus	officer: EVP and CFAO	C/O EQUITABLE HOLDINGS, INC., 1290 AVENUE OF THE AMERICAS, NEW YORK NY 10104
Daniel H. Orenstein	officer: SVP, GC, and Secretary	311 ARSENAL STREET, WATERTOWN MA 02472
Jeremy Delinsky	officer: SVP, Chief Product Officer	C/O WAYFAIR INC., 4 COPLEY PLACE, 7TH FLOOR, BOSTON MA 02116
Timothy M Adams	officer: CFO & SVP	311 ARSENAL STREET, WATERTOWN MA 02472
Bryan E Roberts	director	C/O VENROCK ASSOCIATES, 2494 SAND HILL ROAD STE 200, MENLO PARK CA 94025